40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
86.64%
Revenue growth above 1.5x MTDR's 19.90%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
224.24%
Gross profit growth above 1.5x MTDR's 37.40%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
23983.33%
EBIT growth above 1.5x MTDR's 41.24%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
23983.33%
Operating income growth above 1.5x MTDR's 41.24%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
2022.22%
Net income growth above 1.5x MTDR's 5.48%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
1992.86%
EPS growth above 1.5x MTDR's 5.17%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
1992.86%
Diluted EPS growth above 1.5x MTDR's 5.26%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.92%
Share count expansion well above MTDR's 0.32%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
No Data
No Data available this quarter, please select a different quarter.
-3.59%
Dividend reduction while MTDR stands at 99.70%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-8.87%
Negative OCF growth while MTDR is at 14.87%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-28.64%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-23.01%
Negative 10Y revenue/share CAGR while MTDR stands at 1818.14%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
168.71%
5Y revenue/share CAGR under 50% of MTDR's 439.67%. Michael Burry would suspect a significant competitive gap or product weakness.
3.04%
3Y revenue/share CAGR under 50% of MTDR's 91.94%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-62.17%
Negative 10Y OCF/share CAGR while MTDR stands at 344.25%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
145.99%
Below 50% of MTDR's 619.92%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-2.73%
Negative 3Y OCF/share CAGR while MTDR stands at 73.69%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
419.26%
Below 50% of MTDR's 2189.85%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
425.81%
5Y net income/share CAGR above 1.5x MTDR's 66.98%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-1.27%
Negative 3Y CAGR while MTDR is 54.34%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-82.36%
Negative equity/share CAGR over 10 years while MTDR stands at 155.83%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-45.21%
Negative 5Y equity/share growth while MTDR is at 123.76%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-49.93%
Negative 3Y equity/share growth while MTDR is at 10.94%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-86.10%
Cut dividends over 10 years while MTDR stands at 2995.38%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
70.10%
Dividend/share CAGR of 70.10% while MTDR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
103.48%
3Y dividend/share CAGR of 103.48% while MTDR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-1.74%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
3.07%
Asset growth well under 50% of MTDR's 6.94%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
32.42%
BV/share growth above 1.5x MTDR's 11.15%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-0.22%
We’re deleveraging while MTDR stands at 0.52%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
3.79%
SG&A growth well above MTDR's 2.21%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.